European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.4. Cardiovascular risks. Post-transplant diabetes mellitus.
A. Post-transplant diabetes mellitus (PTDM) should be identified by regular (every 3 months) fasting blood glucose and/or glycated haemoglobin (HbA1c) measurements. PTDM should be treated as appropriate to achieve normoglycaemia. B. Immunosuppressive therapy should be adjusted to reverse or ameliorate PTDM.
D003920:Diabetes Mellitus / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*